InsiderClue
← All stocks

Immunocore Holdings plc

IMCR Net buying
CIK 0001671927 #2109 in the set updated 19 Sep 2026
Bought (120 mo)
$23.99M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$19.45M
$0.00 on a plan · $18.83M straight out of an exercise
Sold at will
$619.08K
4 of 30 sales
Net
+$4.54M
+$23.37M against sales at will

By person

5 insiders · 34 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
BAKER BROS. ADVISORS LP entity
Director
$23.99M (4)
—
+$23.99M
2,144,060
$69.36M
+60.4%
Berman David M
HEAD OF R&D
—
$18.44M (24) scheduled
−$18.44M
5,859
$189.54K
—
St Leger Tina Amber
CHIEF HR OFFICER
—
$618.39K (4) scheduled
−$618.39K
1,119
$36.20K
—
Jallal Bahija
CHIEF EXECUTIVE OFFICER
—
$371.18K (1)
−$371.18K
12,343
$399.30K
—
GOLL JOHN
SVP, FINANCE & CAO
—
$22.58K (1)
−$22.58K
653
$21.12K
—

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Individual transactions

4
Insider
Date
Role
Action
Shares
Price
Amount
BAKER BROS. ADVISORS LP
17 Mar 2025
Director
Buy indirect
92,349
$29.56
$2.73M
BAKER BROS. ADVISORS LP
17 Mar 2025
Director
Buy indirect
8,589
$29.56
$253.89K
BAKER BROS. ADVISORS LP
17 Mar 2025
Director
Buy indirect
646,290
$29.74
$19.22M
BAKER BROS. ADVISORS LP
17 Mar 2025
Director
Buy indirect
60,110
$29.74
$1.79M
Show all 34 transactions →

What was left out

Form 4 filings counted 46
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 3
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 26
Sales at will 4
Transactions with no price 0
Shares from compensation/vesting 427,819
History held since 5 Jan 2024